dc.contributorOndo-Méndez, Alejandro
dc.creatorAgudelo Ramírez, Adriana
dc.date.accessioned2013-02-27T17:04:33Z
dc.date.available2013-02-27T17:04:33Z
dc.date.created2013-02-27T17:04:33Z
dc.date.issued2012
dc.identifierhttp://repository.urosario.edu.co/handle/10336/4278
dc.identifierhttps://doi.org/10.48713/10336_4278
dc.description.abstractGlucose uptake and it´s conversion to lactate plays an important role for tumor metabolism. This phenomena does not depend on oxygen present at the tissue (Warburg effect). This glucose uptake is different between tumors and even into the same tumor. This observation may be depending on tumor microenviroment (fluctuations on oxygen availability and the presence of other non tumoral cell types) and other stress factors associated to the treatments for the disease. We evaluate the effect of hypoxia-reoxigenation (HR) and ionizing radiations (IR) on the glucose uptake, in cell cultures of MCF-7 and HT29 in isolated cultures or cocultured with EAhy926. We found that glucose uptake for the cells exposed to HR were different from that described for the hypoxia conditions. Also we observed that this pattern were modified when tumor cells were cocultured with the endothelial cell line. We identified cell populations in relation to glucose uptake (High, medium, low). We evaluate the nuclear translocation of NRF2 and HIF1a proteins, as an evaluation of hypoxia and cellular stress pathways, finding a possible correlation with breast cancer cells, but no with the colon cell line. This suggest that it may be another pathways involved. The different patterns of glucose uptake and metabolism of tumor cells in relation with glucose uptake, when comparing hypoxia and hypoxia-reoxigenation, could lead to a better dossymmetric planning taking account the variations on oxygen concentration into the tumor.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherMaestría en Ciencias con Énfasis en Genética Humana
dc.publisherFacultad de medicina
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto completo)
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARÁGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización.
dc.sourceAllen, M. & Louise Jones, J., 2011. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. The Journal of pathology, 223(2), pp.162–76. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21125673 [Accessed July 26, 2012].
dc.sourceAristophanous, M. et al., 2012. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning. International journal of radiation oncology, biology, physics, 82(1), pp.e99–105. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21377285 [Accessed October 13, 2012].
dc.sourceArvold, N.D. et al., 2005. Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro. International journal of radiation oncology, biology, physics, 62(1), pp.207–12. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15850923 [Accessed August 15, 2012].
dc.sourceBarton, M.B., Frommer, M. & Shafiq, J., 2006. Role of radiotherapy in cancer control in low-income and middle-income countries. The lancet oncology, 7(7), pp.584–95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16814210.
dc.sourceBertout, J. a, Patel, S. a & Simon, M.C., 2008. The impact of O2 availability on human cancer. Nature reviews. Cancer, 8(12), pp.967–75. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3140692&tool=pmcentrez&rendertype=abstract.
dc.sourceBrahimi-Horn, M.C., Chiche, J. & Pouysségur, J., 2007a. Hypoxia and cancer. Journal of molecular medicine (Berlin, Germany), 85(12), pp.1301–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18026916 [Accessed July 19, 2012].
dc.sourceBrahimi-Horn, M.C., Chiche, J. & Pouysségur, J., 2007b. Hypoxia signalling controls metabolic demand. Current opinion in cell biology, 19(2), pp.223–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17303407 [Accessed July 19, 2012].
dc.sourceBusk, M. et al., 2008. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. European journal of nuclear medicine and molecular imaging, 35(12), pp.2294–303. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18682937 [Accessed October 13, 2012].
dc.sourceCairns, R. a, Harris, I.S. & Mak, T.W., 2011. Regulation of cancer cell metabolism. Nature reviews. Cancer, 11(2), pp.85–95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21258394 [Accessed July 13, 2012].
dc.sourceChristian, N. et al., 2010. Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 97(2), pp.183–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20304513 [Accessed October 13, 2012].
dc.sourceDewhirst, M.W. et al., 2007. Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 83(3), pp.249–55. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2694841&tool=pmcentrez&rendertype=abstract [Accessed October 15, 2012].
dc.sourceDewhirst, M.W., 2009. Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress. Radiation research, 172(6), pp.653–65. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2790140&tool=pmcentrez&rendertype=abstract [Accessed October 21, 2012].
dc.sourceDewhirst, M.W., Cao, Y. & Moeller, B., 2008. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nature reviews. Cancer, 8(6), pp.425–37. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18500244 [Accessed July 19, 2012].
dc.sourceEdited By Celis, J.E., 2006. CELL BIOLOGY A LABORATORY HANDBOOK 3rd ed. J. E. Celis, ed., ELSEVIER.
dc.sourceFarmer, P. et al., 2010. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet, 376(9747), pp.1186–93. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20709386 [Accessed October 8, 2012].
dc.sourceGatenby, R. a & Gillies, R.J., 2004. Why do cancers have high aerobic glycolysis? Nature reviews. Cancer, 4(11), pp.891–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15516961 [Accessed July 13, 2012].
dc.sourceGoldberg, M.A., Dunning, S.P. & Bunn, H.F., 1988. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science (New York, N.Y.), 242(4884), pp.1412–5. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2849206 [Accessed October 14, 2012].
dc.sourceGregoire, V. & Chiti, A., 2010. PET in radiotherapy planning: particularly exquisite test or pending and experimental tool? Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 96(3), pp.275–6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20708810 [Accessed October 13, 2012].
dc.sourceHalestrap, A.P. & Price, N.T., 1999. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. The Biochemical journal, 343 Pt 2, pp.281–99. Available at: http://www.sciencedirect.com/science/article/pii/S0955067497800683 [Accessed October 25, 2012].
dc.sourceHall D.Phil, Eric J. Giaccia, A.J., 2006. Radiobiology for the Radiologist 6th ed., Lippincott Williams & Wilkins.
dc.sourceHanahan, D & Folkman, J., 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86(3), pp.353–64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8756718.
dc.sourceHanahan, Douglas & Weinberg, R. a, 2011. Hallmarks of cancer: the next generation. Cell, 144(5), pp.646–74. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21376230 [Accessed July 12, 2012].
dc.sourceHanahan, Douglas & Weinberg, R.A., 2000. The hallmarks of cancer. Cell, 100(1), pp.57–70. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10647931 [Accessed October 4, 2012].
dc.sourceHassanein, M. et al., 2011. Development of high-throughput quantitative assays for glucose uptake in cancer cell lines. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 13(5), pp.840–52. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20809209 [Accessed September 17, 2012].
dc.sourceInstituto Nacional de Cancerología, I., 2010. Mortalidad Nacional por tipo de Cáncer. Available at: http://www.cancer.gov.co/documentos/Mortalidad/Mor.
dc.sourceKe, Q. & Costa, M., 2006. Hypoxia-inducible factor-1 (HIF-1). Molecular pharmacology, 70(5), pp.1469–80. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16887934 [Accessed October 29, 2012].
dc.sourceKim, J., Gao, P. & Dang, C.V., 2007. Effects of hypoxia on tumor metabolism. Cancer metastasis reviews, 26(2), pp.291–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17415528 [Accessed October 15, 2012].
dc.sourceKim, T., Hur, E. & Kang, S., 2011. NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1 α. , pp.2260–2275.
dc.sourceKizaka-Kondoh, S. et al., 2009. The HIF-1-active microenvironment: an environmental target for cancer therapy. Advanced drug delivery reviews, 61(7-8), pp.623–32. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19409433 [Accessed October 15, 2012].
dc.sourceKorreman, S. et al., 2010. The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 94(2), pp.129–44. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20153908 [Accessed October 9, 2012].
dc.sourceKurien, B.T. & Scofield, R.H., 2006. Western blotting. Methods (San Diego, Calif.), 38(4), pp.283–93. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16483794 [Accessed July 19, 2012].
dc.sourceLau, A. et al., 2008. Dual roles of Nrf2 in cancer. Pharmacological research : the official journal of the Italian Pharmacological Society, 58(5-6), pp.262–70. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2652397&tool=pmcentrez&rendertype=abstract [Accessed August 10, 2012].
dc.sourceLee, S. et al., 2012. An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses. Free radical biology & medicine, 53(4), pp.807–16. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22684019 [Accessed October 15, 2012].
dc.sourceLiu, W. et al., 2012. Targeted genes and interacting proteins of hypoxia inducible factor-1. International journal of biochemistry and molecular biology, 3(2), pp.165–78. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3388736&tool=pmcentrez&rendertype=abstract.
dc.sourceMagesh, S., Chen, Y. & Hu, L., 2012. Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents *. , (4), pp.687–726.
dc.sourceMarín-Hernández, A. et al., 2011. Modeling cancer glycolysis. Biochimica et biophysica acta, 1807(6), pp.755–67. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21110941 [Accessed August 15, 2012].
dc.sourceMcDonald, J.T. et al., 2010. Ionizing radiation activates the Nrf2 antioxidant response. Cancer research, 70(21), pp.8886–95. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2970706&tool=pmcentrez&rendertype=abstract [Accessed July 17, 2012].
dc.sourceMinisterio de la Protección Social, M.P.S. & Instituto Nacional de Cancerología, I., 2010. Plan nacional para el control del cáncer en Colombia 2010 - 2019. Available at: http://www.cancer.gov.co/contenido/contenido.aspx?conID=1061&catID=1 [Accessed July 15, 2012].
dc.sourceMoeller, B.J. et al., 2004. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer cell, 5(5), pp.429–41. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15144951.
dc.sourceMoi, P. et al., 1994. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proceedings of the National Academy of Sciences of the United States of America, 91(21), pp.9926–30. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=44930&tool=pmcentrez&rendertype=abstract.
dc.sourceMorgan, W.F. & Sowa, M.B., 2007. Non-targeted bystander effects induced by ionizing radiation. Mutation research, 616(1-2), pp.159–64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17134726 [Accessed August 15, 2012].
dc.sourceMunshi, A., Hobbs, M. & Meyn, R.E., 2005. Clonogenic cell survival assay. Methods in molecular medicine, 110, pp.21–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15901923 [Accessed July 24, 2012].
dc.sourceNakajima, E.C. & Van Houten, B., 2012. Metabolic symbiosis in cancer: Refocusing the Warburg lens. Molecular carcinogenesis, (November), pp.1–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22228080 [Accessed July 30, 2012].
dc.sourceOrganización Mundial de la Salud, O., 2009. CENTRO DE PRENSA. CÁNCER, DATOS Y CIFRAS. , p.http://www.who.int/mediacentre/factsheets/fs297/es. Available at: http://www.who.int/mediacentre/factsheets/fs297/es [Accessed July 15, 2012].
dc.sourceOsburn, W.O. & Kensler, T.W., 2008. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutation research, 659(1-2), pp.31–9. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2585047&tool=pmcentrez&rendertype=abstract [Accessed October 15, 2012].
dc.sourceO’Neil, R.G., Wu, L. & Mullani, N., 2005. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 7(6), pp.388–92. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16284704 [Accessed September 17, 2012].
dc.sourcePark, J.E. et al., 2010. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Molecular & cellular proteomics : MCP, 9(6), pp.1085–99. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2877972&tool=pmcentrez&rendertype=abstract [Accessed October 24, 2012].
dc.sourceQuintero, P., 2012. Estudio in vitro de la supervivencia en células tumorales irradiadas con un acelerador lineal de uso clínico. Universidad Nacional de Colombia.
dc.sourceRzeszowska-Wolny, J., Przybyszewski, W.M. & Widel, M., 2009. Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy. European journal of pharmacology, 625(1-3), pp.156–64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19835860 [Accessed August 15, 2012].
dc.sourceRødningen, O.K. et al., 2005. Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 77(3), pp.231–40. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16297999 [Accessed August 15, 2012].
dc.sourceSalud, O.M. de la, GLOBOCAN Cancer Incidence, Mortality and Prevalence Worldwide in 2008. , p.http://globocan.iarc.fr/factsheet.asp.
dc.sourceSattler, B. et al., 2010. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 96(3), pp.288–97. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20709416 [Accessed October 13, 2012].
dc.sourceSemenza, G.L. et al., 1991. Hypoxia-inducible nuclear factors bind to an enhancer element located 3’ to the human erythropoietin gene. Proceedings of the National Academy of Sciences of the United States of America, 88(13), pp.5680–4. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=51941&tool=pmcentrez&rendertype=abstract [Accessed October 14, 2012].
dc.sourceSemenza, G.L., 2003. Targeting HIF-1 for cancer therapy. Nature reviews. Cancer, 3(10), pp.721–32. Available at: http://www.ncbi.nlm.nih.gov/pubmed/13130303 [Accessed October 5, 2012].
dc.sourceSonveaux, P. et al., Targeting lactate-fueled respiration as a new antitumor strategy. , (12), pp.13–16.
dc.sourceSonveaux, P. et al., 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. The Journal of clinical investigation, 118(12), pp.3930–42. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2582933&tool=pmcentrez&rendertype=abstract [Accessed October 11, 2012].
dc.sourceTsukimoto, M. et al., 2010. Low-Dose Gamma-Ray Irradiation Induces Translocation of Nrf2 Into Nuclear in Mouse Macrophage RAW264.7 Cells. Journal of Radiation Research, 51(3), pp.349–353. Available at: http://joi.jlc.jst.go.jp/JST.JSTAGE/jrr/10002?from=CrossRef [Accessed August 23, 2012].
dc.sourceVaupel, P. & Mayer, A., 2007. Hypoxia in cancer: significance and impact on clinical outcome. Cancer metastasis reviews, 26(2), pp.225–39. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17440684 [Accessed July 14, 2012].
dc.sourceVogin, G., 2011. [Radiosensitivity, radiocurability and DNA repair]. Cancer radiothérapie : journal de la Société française de radiothérapie oncologique, 15(4), pp.294–306. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21334945 [Accessed October 8, 2012].
dc.sourceWeizmann Institute of Science, W., 2012. Gene Cards. The Human Gene Compendium. Available at: http://www.genecards.org [Accessed June 24, 2012].
dc.sourceWu, Q. et al., 2011. Bystander effect in human hepatoma HepG2 cells caused by medium transfers at different times after high-LET carbon ion irradiation. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 269(2), pp.153–158. Available at:
dc.sourceXu, X. et al., 2008. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer letters, 261(2), pp.147–57. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18171602 [Accessed August 15, 2012].
dc.sourceZaider, M. & Hanin, L., 2011. Tumor control probability in radiation treatment. Medical Physics, 38(2), p.574.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectHipoxia-reoxigenación
dc.subjectEfecto Warburg
dc.subjectNRF2
dc.subjectRadiaciones ionizantes
dc.subjectCáncer de seno y colon
dc.subjectCocultivo
dc.subjectHIF1a
dc.subjectSimbiosis metabólica
dc.titleEfecto de la hipoxia-reoxigenación y las radiaciones ionizantes en la captación de glucosa en líneas tumorales de seno y colon cocultivadas con células endoteliales.
dc.typemasterThesis


Este ítem pertenece a la siguiente institución